This is further supported by TCGA data that indicates the elevated expression levels in tumor tissue as a differentiating characteristic compared to CRBN, the most-frequently pursued E3 ligase for TPD applications (Supplementary Fig. 5d, e). Here, CRBN is linked to neoplasm.